Acetyl-L-Carnitine hydrochloride
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Acetyl-L-Carnitine hydrochloride, covering 2014-12-31 to 2014-12-31. Get the full timeline:
Most recent: Clinical Trial Update: Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy [Phase 3]